Thiamine for Coronary Artery Bypass Surgery
(B1&CABG Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if thiamine, a low-cost vitamin, can reduce memory and thinking problems after heart surgery, specifically coronary artery bypass grafting (CABG). Researchers will compare patients receiving thiamine with those who do not to identify any differences in cognitive health and related blood markers. Suitable candidates have coronary heart disease, are scheduled for CABG, and have low thiamine levels. As an Early Phase 1 trial, this research focuses on understanding thiamine's effects in people, offering participants a chance to contribute to groundbreaking insights.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are currently taking thiamine.
Is there any evidence suggesting that thiamine is likely to be safe for humans?
Research has shown that thiamine, or Vitamin B1, is generally safe during heart surgery. One study found that patients who received high doses of thiamine during heart surgery tolerated it well, with no major safety issues. Some studies also suggest that thiamine, when combined with Vitamin C, can help reduce inflammation and heart muscle damage. However, since this trial is in an early stage, it primarily explores how thiamine might improve brain function after heart surgery and its safety in this specific context. This phase usually involves smaller patient groups, so more information is needed about its safety and benefits.12345
Why do researchers think this study treatment might be promising?
Unlike standard treatments for post-CABG recovery, which typically focus on managing cardiovascular health and reducing complications, thiamine is being explored for its potential cognitive benefits. Researchers are excited about thiamine because it's a vitamin that could improve brain function and reduce inflammation after surgery. While many treatments target heart function and circulation, thiamine works differently by potentially enhancing cognitive recovery and lowering levels of lactate and inflammatory markers, which are vital for overall healing. This approach could offer a new way to support patients' recovery beyond the traditional focus on heart health alone.
What evidence suggests that thiamine might be an effective treatment for post-CABG cognitive issues?
Research has shown that thiamine, or vitamin B1, might benefit individuals undergoing coronary artery bypass surgery (CABG). Thiamine levels often drop significantly after this surgery, potentially leading to issues like elevated lactate levels that can hinder recovery. Some studies suggest that taking thiamine before surgery can help reduce these lactate levels. This trial will compare post-CABG patients receiving thiamine treatment with those receiving a placebo to assess its impact on recovery and cognitive function. Although more research is needed, thiamine appears to be a promising and affordable option for aiding recovery after CABG.14678
Who Is on the Research Team?
Rajesh Kumar, PhD
Principal Investigator
University of California, Los Angeles
Are You a Good Fit for This Trial?
This trial is for individuals with coronary heart disease who are scheduled to undergo coronary artery bypass grafting (CABG). Participants should be interested in exploring if thiamine can help reduce cognitive issues after surgery.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive thiamine or placebo treatment and undergo cognitive assessments and blood evaluations
Follow-up
Participants are monitored for long-term effects on cognition, daily activities, and quality of life
What Are the Treatments Tested in This Trial?
Interventions
- Thiamine
Thiamine is already approved in United States, European Union, Canada for the following indications:
- Thiamine deficiency
- Beriberi
- Wernicke-Korsakoff syndrome
- Thiamine deficiency
- Beriberi
- Wernicke-Korsakoff syndrome
- Thiamine deficiency
- Beriberi
- Wernicke-Korsakoff syndrome
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Los Angeles
Lead Sponsor
National Institute on Aging (NIA)
Collaborator